News

If you had to choose a stock for the investing hall of shame over the last decade, AT&T (NYSE: T) would be a good candidate.

It's made two of the worst acquisitions of this century, spending more

Telecom giant AT&T (NYSE: T) surprised investors on Thursday with third-quarter results that sent its stock flying. Not only did AT&T beat analyst expectations for both revenue and earnings per

Shares of Summit Materials (NYSE: SUM) were up 8% as of 11:30 a.m. ET on Thursday after the construction materials provider filed a preliminary statement with the Securities and Exchange Commission

Image source: The Motley Fool.

AT&T (NYSE: T)Q3 2023 Earnings CallOct 19, 2023, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Biotech stocks have been beaten down in 2023, with the sector off nearly 4% this year while the S&P 500 is up more than 15%. But some of the larger, better known biotech stocks have thrived --

For a company in the midst of a transition away from the medicine that made it a star performer over the last decade, AbbVie's (NYSE: ABBV) valuation looks surprisingly high. Why is the market

Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) have been in agreement on a lot since the beginning of the pandemic. They both recognized the importance of eventually launching combined vaccines --

Image source: The Motley Fool.

Abbott Laboratories (NYSE: ABT)Q3 2023 Earnings CallOct 18, 2023, 9:00 a.m. ET

Operator

Continue reading

Source Fool.com

Shares of Ardelyx (NASDAQ: ARDX) were up 13.2% as of 2:30 p.m. ET Wednesday after the U.S. Food and Drug Administration (FDA) approved its first-in-class chronic kidney disease drug. In a press

Diabetes care and aesthetics. Those are two areas of healthcare that should provide investors with ample growth opportunities in the long run. Two companies that are in solid positions to capitalize

Exelixis (NASDAQ: EXEL) is not exactly a household name in the biotech industry, but that hasn't stopped the company from crushing the market this year -- rising over 30%. Perhaps one key reason

Stocks that are crashing in value can sometimes make for good contrarian investments -- provided that there's a reason to expect a turnaround. But in some situations, investors are better off just

Healthcare ranks as one of the top expenses for many retirees. And it's about to become even more expensive.

Last week, the Centers for Medicare and Medicaid Services (CMS) announced the amounts of

Cathie Wood isn't known for being a value investor. However, the Ark Invest CEO won't pass up the opportunity to scoop up shares of innovative companies when they're available at a lower price.

Pharmaceutical giant Pfizer (NYSE: PFE) wasn't looking very tall or strong on the stock exchange Tuesday. The company's share price dipped by nearly 2% over the course of the trading session

Industries with endless demand are great places to find dividend stocks. Healthcare might be the best example of this. No matter how much technology changes, the need to prevent and treat disease

Although sometimes risky and volatile, the biotech industry is an excellent place to find stocks that can generate steady returns for years. That's because these companies tend to offer products

Telecom giant AT&T (NYSE: T) has been through a lot in recent years.

The company's foray into entertainment media operations ended with the spinoff of WarnerMedia to create the new Warner Bros

This vaccination season could be a key moment for vaccine makers and investors. That's because it's offering us a first glimpse into the future coronavirus vaccine revenue opportunity. Companies

If you're looking for income-generating investments to fuel your retirement dreams, it's hard to go wrong with dividend-paying stocks in the healthcare sector. After all, people need medical care

Want to invest in stocks that you can buy and forget about? If so, you'll want to consider companies with plenty of long-term growth opportunities and solid financials. Among the best growth